Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Griffin P. Rodgers, MD, MACP
Researcher Director
National Institute of Diabetes
and Digestive and Kidney Diseases
Building 31, Room 9A52
31 Center Drive
Bethesda, Maryland, United States
Dr. Griffin Rodgers, Director of the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases, is an accomplished clinician, researcher, and mentor, and is a role model.
His research interests include genetic diseases: sickle cell anemia, thalassemia, red cell enzymopathies; clinical evaluation of disease severity; treatment, including pharmacological alteration of gene expression and stem cell transplantation; molecular genetics of human hemoglobins; gene expression and differentiation in erythroid cells in normal and perturbed hematopoietic states; pharmacological alteration of gene expression; molecular genetics of myleodysplastic and myleoproliferative syndromes; hematopoiesis; role of inducible and stochastic factors; hematopoietic stem cell plasticity; identification of early markers of lineage-specific differentiation; the development of novel gene therapy strategies and their targeted application in cord blood hematopoietic stem cells.
As a research investigator, Dr. Rodgers is widely recognized for his contributions to the development of hydroxyurea, the first effective—and now FDA approved—therapy for sickle cell anemia.
Representative Publications:
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease
HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell disease
Hemolytic anemia-associated pulmonary hypertension in sickle cell disease
+myBinderRelated Content
-
Stuart H. Orkin, MDDr. Orkin is David G. Nathan Distinguish...
-
Stigmatizing language in medical records affects patient care, study showsPhysicians who use stigmatizing langua...
-
University of North Carolina at Chapel Hill School of Medicine, Division of Hematology/OncologyThe Division of Hematology/Oncology offe...
-
John J. Strouse, MD, PhDJohn J. Strouse is currently working as ...
-
Risk Factors for 30-Day Readmission in Adults with Sickle Cell DiseaseBACKGROUND: Readmission to the hospital...
-
Sickle Cell Program at UI HealthThe Sickle Cell Program at UI Health is ...
-
DDCF Awards $6 Million for Sickle Cell Disease ResearchThe Doris Duke Charitable Foundation has...
